middle.news
Neuren’s Royalties Climb as Profit Dips Amid Phase 3 Push and Dividend Debut
9:25am on Wednesday 26th of August, 2026 AEST
•
Healthcare
Read Story
Neuren’s Royalties Climb as Profit Dips Amid Phase 3 Push and Dividend Debut
9:25am on Wednesday 26th of August, 2026 AEST
Key Points
DAYBUE royalties up 29% in US dollars
Profit after tax down 68% to A$4.9 million
First fully franked interim dividend declared
Phase 3 Koala trial enrolment expands
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neuren Pharmaceuticals (ASX:NEU)
OPEN ARTICLE